GovChime
Notice ID: 8f5e346353fc46ddb1224789f6356722PresolicitationArchived

FY26 Recompete of the Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program

Archived on September 26, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM CDT
Posted
September 8, 2026
Notice type
Presolicitation
NAICS
334510: Electromedical and Electrotherapeutic Apparatus Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
COMMODITIES & SERVICES ACQUISITION SERVICE (36C791)
Place of performance
Colorado, 80401
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
36C791-27-AP-0004-0002
Notice ID
8f5e346353fc46ddb1224789f6356722

Description

The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Enterprise Procurement Office (EPO), is releasing an updated edition of the FY26 Recompete Electro‑Therapeutic Modalities for Pain Management (ETMPM) & Transcutaneous Electrical Nerve Stimulation (TENS) Program – Consolidated Request for Information (RFI) Frequently Asked Questions (FAQs). This update incorporates all questions received during the January 20, 2026 and June 25, 2026, RFI cycles, inputs submitted during the FY26 Denver Logistics Center (DLS) Industry Days and newly received industry inquiries submitted during August–September 2026. These updated FAQs continue to support uniform, transparent communication with industry during the market research and presolicitation phases, and they remain strictly informational in accordance with FAR 15.201(e). They do not establish proposal requirements, do not constitute Government direction, and do not provide a competitive advantage to any party. Additionally, the VA is releasing a targeted, Request for Information (RFI). This posting continues the VA’s commitment to transparent, enterprise‑wide communication throughout the market research and presolicitation phases of this national procurement. These exchanges remain strictly informational and are conducted in accordance with FAR 15.201(e); no guidance herein constitutes direction, evaluation criteria, or binding requirements. Final, enforceable requirements will be issued exclusively in the solicitation on SAM.gov.

Acknowledging Industry RFI Fatigue: The VA recognizes that industry partners have already responded to two (2) extensive RFI cycles on January 20, 2026, and June 25, 2026, and that many vendors have expressed RFI fatigue. This feedback is both heard and valid. However, the FY26 ETMPM–TENS Recompete is a national, enterprise‑wide, multi-year, multi-modality procurement, spanning:

  • Five distinct device categories (TENS, IFC, SWD Thermal, SWD Non‑Thermal, Neuromodulation);
  • Twenty‑plus accessory categories (electrodes, cables, gels/sprays, chargers, garment‑based solutions);
  • CLIN‑level therapeutic devices and SLIN‑level consumables;
  • Full compliance with the Buy American Act (BAA) and Trade Agreements Act (TAA) for every item offered;
  • Distribution across 168 VA Medical Centers and 1,000+ outpatient clinics nationwide.

Because the procurement is so structurally complex and because the VA uncovered significant gaps and inconsistencies in early RFI submissions, the VA must now issue another RFI focused exclusively on Country‑of‑Origin (COO) identification at the CLIN and SLIN level. This step is not repetitive; it resolves the final missing data required to complete the solicitation package.

Why This Third RFI Is Necessary (Based on Prior RFI Analysis): Analysis of responses to the first two RFIs revealed several industry‑wide issues:

1. COO data was incomplete or inconsistent across submissions: Some vendors provided COO at the corporate level, others only at the device level, while many did not provide COO at the SLIN (accessory) level at all.

2. Multiple accessory items lacked origin information entirely: Electrodes, gels, conductive sprays, garment‑based pads, charging blocks, and lead wires frequently had unknown, mixed, or conflicting COO information, making BAA/TAA verification impossible.

3. Several respondents listed product families rather than itemized CLIN/SLIN offerings: This made it impossible for the VA to map COO to each distinct end‑product, which is required by FAR Part 25.

4. Initial RFIs revealed significant variance in supply chains: Some OEMs source components from multiple countries over a given production cycle. The VA must ensure traceability and compliance for every end‑product actually offered for contract award.

5. Without verified COO at the CLIN/SLIN level, the VA cannot finalize:

  • BAA/TAA compliance determinations,
  • CLIN/SLIN eligibility for award,
  • Pricing matrices in the solicitation,
  • Mandatory certifications,
  • Whether any CLINs or SLINs require BAA non‑availability waivers.

In short, without accurate COO data, the VA cannot legally or structurally finalize the solicitation.

Issuance of the Third RFI — What It Is and What It Isn’t: This RFI, titled“FY26 ETMPM & TENS Procurement Program – Country‑of‑Origin & Product Characteristics RFI” is not a repeat of the earlier RFIs. Instead, it is a targeted, single‑purpose data call designed to close the last remaining gap identified through market research, the precise Country‑of‑Origin for each CLIN‑level device and SLIN‑level accessory in your planned proposal. Once COO data is received and validated, the VA will finalize:

  • CLIN/SLIN schedules,
  • Compliance language,
  • BAA/TAA clauses,
  • Evaluation factors,
  • Section B pricing structures,
  • Attachment 0002 - Price Matrices, and
  • All certification requirements for the solicitation.

How Tiered Set‑Aside Evaluation Drives COO Identification at Pre‑Solicitation: The FY26 ETMPM–TENS procurement program is employing a Tiered Set‑Aside (Cascading) Evaluation under NAICS 334510 – Electromedical and Electrotherapeutic Apparatus Manufacturing (size standard: 1,250 employees). Awards are pursued at the highest tier where acceptable offers and fair‑and‑reasonable prices exist; if award cannot be made at a higher tier, evaluation cascades to the next tier, and may ultimately result in award at the lowest tier (other‑than‑small business or large business concerns).

Source Selection Methods by CLIN:

  • CLINs X001–X004 (TENS/IFC/SWD – COTS items): LPTA procedures will be used within the tiered framework; past performance is a pass/fail evaluation based on three (3) past performance documents, technical acceptability is evaluated against the proposal documentation and product samples CLIN/SLIN Minimum Technical Requirements (MTRs) on a pass/fail basis, and the price factor is significantly more important than the past performance or technical evaluation considerations. The price factor will be evaluated based on the Total Evaluated Price (TEP) based on each Offeror’s Attachment 0002 - Price Matrix submission.   
  • CLIN X005 (Neuromodulation – Commercial item): Best Value – Tradeoff procedures apply adjectival rating methodology based on Technical factor (weighted at 60%) and Past Performance factor (weighted at 15%) combined are significantly more important than Price factor (weighted at 25%).

Award Inclusivity of SLINs for CLIN X001 and CLIN X002: To ensure technical compatibility and accessory interoperability, any award for:

  • CLIN X001 (TENS Device) is inclusive of the TENS device accessories SLINs X001AA, X001AB, X001AC, X001AD; and
  • CLIN X002 (IFC Device) is inclusive of the IFC device accessories SLINs X002AA, X002AB, X002AC, X002AD.
  • Offerors must submit responsive proposals on both the parent CLIN and all subordinate SLINs; pricing for the parent CLIN is evaluated with the associated SLINs.

BAA/TAA Application by Tier (Why COO Is Needed Now): Under the tiered evaluation approach, the statutory trade rules differ by tier, which is why the VA must verify COO at the CLIN and SLIN level before releasing the RFP:

  • Small‑Business tiers (SDVOSB/VOSB/other small business concerns): The VA centers evaluation on Buy American Act (BAA) compliance for end‑products offered by small business concerns; COO determines whether items qualify as Domestic End Products, or if a BAA non‑availability waiver might need consideration.
  • Other‑than‑Small Business tiers (e.g., large business): At the anticipated dollar values of this enterprise procurement, the Trade Agreements Act (TAA) applies to offers from large businesses; COO determines if offered items originate in TAA‑designated countries (eligible) or fall into non‑designated countries (ineligible).

Because award can be made at any tier depending on competition outcomes (highest tier possible (small business concerns), lowest tier if necessary (large business concerns)), the program must pre‑validate COO for every CLIN and SLIN to ensure the solicitation contains correct BAA/TAA clauses, certifications, and evaluation rules for all competition outcome contingencies without delaying award decisions or risking non‑compliant sources.

What the COO RFI Collects (Pre‑Solicitation): The RFI requests each respondent to identify the COO for each product you plan to offer the VA for this procurement effort:

  • CLIN/SLIN identification, SKU/part numbers, HCPCS;
  • COO classification (BAA Domestic, TAA‑Designated, or Non‑Designated); and
  • Ability to provide formal COO certification at proposal submission.
    This one‑time data call enables the VA to finalize CLIN/SLIN schedules, solicitation compliance language, pricing matrices, and certifications that will govern LPTA decisions on X001–X004 and Best‑Value tradeoffs on X005 within the Tiered Set‑Aside structure.

Why COO Matters for This Procurement: Under FAR Part 25, the VA must determine whether every product offered is:

  • A Domestic End Product under BAA (in play for small business concerns);
  • A TAA‑designated Country End Product (in play for large business concerns); or
  • A Non‑Designated Country End Product (generally prohibited from procurement unless eligible for BAA non-availability waiver).

Because the ETMPM–TENS Program includes multiple device modalities, a wide slate of accessories, and SKU‑level consumables, COO must be confirmed for each unique CLIN/SLIN end‑product, not generically referenced. This ensures:

  • Protection against gray‑market goods;
  • Supply chain integrity for Veteran patient care;
  • Compliance with federal law;
  • Eligibility determinations for each CLIN/SLIN in the solicitation;
  • Proper evaluation structure for the Best Value Tradeoff and LPTA CLINs;
  • Ability to establish uniform national standards across all VA medical facilities.

RFI Issuance: This RFI requests that all interested industry respondents provide Country‑of‑Origin (COO) information for every product offered under each CLIN and SLIN. COO certification is required under FAR Part 25, including Buy American Act (BAA) and Trade Agreements Act (TAA) considerations. To support compliant solicitation development, the VA must confirm:

  • Whether proposed CLIN‑level therapeutic devices (TENS, IFC, SWD Thermal, SWD Non‑Thermal, and Neuromodulation) are Domestic End Products under the BAA;
  • Whether proposed CLIN/SLIN‑level items (electrodes, gel/spray consumables, lead wires, power accessories, garment‑based options) qualify as TAA‑designated end‑products;
  • Whether any items originate from non‑designated countries, which would require evaluation for potential BAA non‑availability waivers;
  • Whether vendors can provide formal COO certification at the time of solicitation submission.
     

Why the VA Requires COO Data Before Solicitation Release: The collecting of the COO information at the CLIN and SLIN level is essential for:

  1. Ensuring FAR Part 25 compliance (BAA/TAA) across all product categories under this enterprise procurement;
  2. Finalizing solicitation language regarding eligibility of domestic and designated‑country end‑products;
  3. Determining whether any CLINs or SLINs require BAA non‑availability waiver consideration;
  4. Protecting VA supply chain integrity, preventing procurement of non‑compliant or gray‑market products;
  5. Establishing accurate evaluation criteria and certification requirements for the technical and price factors;
  6. Ensuring enterprise‑wide standardization of clinically essential devices and accessories across 168 VA Medical Centers, 1,000+ CBOCs, and federal partner sites.

The VA cannot finalize the solicitation, CLIN/SLIN schedules, or product compliance requirements without receiving complete COO data for all prospective offerings.

Instructions for Respondents Completing the RFI: Industry partners are requested to:

  1. Download and complete the RFI template (attached to this posting).
  2. Provide detailed COO information for every CLIN and SLIN they intend to offer.
  3. Convert the completed document to PDF, digitally sign, and date it.
  4. Email it to:
    • john.overstake@va.gov
    • Subject line: “RFI Response – ETMPM/TENS Program – [Company Name]”
  5. Ensure submission includes all required product data, such as:
    • CLIN/SLIN identification
    • Product descriptions and technical specifications
    • HCPCS information
    • SKU/part numbers
    • COO classification (BAA Domestic, TAA‑Designated, or Non‑Designated)
       

Closing Remarks:

We understand that responding to repeated RFIs consumes time, personnel, and resources. Industry partners have been exceptionally responsive, and the VA genuinely appreciates the participation across all phases of the FY26 procurement cycle. The VA recognizes the burden this places on vendors and does not issue this RFI lightly. This step is essential to protect Veterans, federal supply chain integrity, and statutory compliance requirements that govern VA acquisitions. Your continued partnership enables the VA to move this large, complex, mission‑critical procurement into the solicitation phase with confidence, clarity, and regulatory compliance. The VA sincerely appreciates your patience and professionalism as we work to ensure that Veterans nationwide receive safe, FDA‑cleared, clinically reliable electro‑therapeutic devices backed by a compliant, stable, and modernized acquisition structure. All future updates including release of the formal RFP will be published exclusively on SAM.gov.

Full description on SAM.gov

Award Overview

Possible prior contract

Inferred, not confirmed

Inferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.

Contract end date

Sep 30, 2025

NAICS

334510

Agency

Department of Veterans Affairs

Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.

Contacts

Contracting Officer

Primary Contact

John Overstake - Contract Specialist

Secondary Contact

Maurice Walker - Supervisory Contracting Officer

Documents

Files (2)

  • P02_FY26 ETMPM and TENS Procurement Program_RFI_Template.docx

    84 KBAdded in Presolicitation version 4Posted
    Download
  • S05_RFI FAQs_Government Responses_FY26 ETMPM-TENS Procurement Program_Final_Issued 08SEP2026.pdf

    122 KBAdded in Presolicitation version 4Posted
    Download

Lifecycle

  1. 4
    Version 4PresolicitationArchivedCurrent

    FY26 Recompete of the Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program

    Notice 8f5e346353fc46ddb1224789f6356722 on SAM.gov

  2. 2
    Version 2Solicitation

    Type changed from Presolicitation to Solicitation

    Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program

    Notice 890afe0afe83440e9f07ed7a08d8f79e on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Solicitation Notice: 36C79126R0011 – Electro-Therapeutic Modalities for Pain Management (ETMPM) – Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program Notice Type: Solicitation Issuance Notice Solicitation Number: 36C79126R0011 Posted Date: September 18, 2026 Response Due Date: October 19, 2026, 3:00 PM Central Daylight Time (CDT) NAICS Code: 334510 – Electromedical and Electrotherapeutic Apparatus Manufacturing. The Small Business size standard for NAICS Code 334510 is 1,250 employees. This NAICS code is appropriate as it encompasses the manufacturing of FDA‑regulated electromedical therapeutic equipment including TENS, IFC, neuromodulation, and diathermy devices. PSC: 6515 – Medical and Surgical Instruments, Equipment, and Supplies Set-Aside: The Tiered Set-Aside Evaluation Approach used by the VA is not classified as a traditional Small Business set-aside, but rather as a competitive negotiated procurement, conducted via a tiered evaluation process aimed at prioritizing award to successive small business categories. This acquisition will be conducted using the VA Tiered Set‑Aside Evaluation Approach pursuant to the authority of 38 U.S.C. 8127, including the statutory priority ordering prescribed in 38 U.S.C. § 8127(h) (a subsection of the Veterans First Contracting Program statute) and the procedures outlined in Veteran Affairs Acquisition Regulation (VAAR) 815.101‑370 (Class Deviation). Under this approach, the Government will solicit offers from all tiers of Offerors simultaneously; however, proposal evaluations and award determination will occur sequentially in the prescribed order of priority. The tiers for this procurement are as follows: Tier-1 Service‑Disabled Veteran‑Owned Small Business (SDVOSB): SDVOSBs shall be evaluated first in accordance with VA’s statutory obligation to prioritize verified SDVOSBs when the VA Rule of Two is met. If no award can be made at Tier-1, then verified VOSB offers will be evaluated next in Tier-2, consistent with the Veterans First hierarchy. Tier-2 Veteran‑Owned Small Business (VOSB): If no award can be made at Tier 2, the Government will evaluate offers from all other eligible small business concerns, (e.g., 8(a), HUBZone, and WOSB are considered before considering other small business concerns), in Tier 3 following the tiering procedures established in VAAR 815.101-3 and VAAR 815.101-370 (Class Deviation). Tier-3 Other Small Business Concerns: If no award can be made at Tier-3, the Government will evaluate offers from all Other-Than-Small-Business (OTSB) Concerns (Large Businesses)) in Tier 4 following the tiering procedures established in VAAR 815.101‑3 and 815.101‑370 (Class Deviation). Tier-4 Other‑Than‑Small Business (OTSB) Concerns (Large Businesses): If no award can be made under any small business Tier 1 through 3, the Government will evaluate offers from other‑than‑small businesses or large business concerns in Tier 4. This tiered evaluation methodology is authorized under 38 U.S.C. 8127 and implemented through the VA’s Class Deviation to VAAR 815.101‑370, which permits the use of tiered set‑aside procedures to minimize procurement delays in situations where market research indicates that award at the SDVOSB or VOSB tiers is uncertain. Contracting Office: Department of Veterans Affairs, Enterprise Procurement Office, Acquisition Service Four Delta Team, 555 Corporate Circle, Golden, CO 80401-5621. Introduction: The Department of Veterans Affairs (VA) is pleased to announce the release of Solicitation Number 36C79126R0011, the official Request for Proposals (RFP) for the Electro-Therapeutic Modalities for Pain Management (ETMPM) – Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program. The objective of this national procurement program is to establish multiple single-awards of Firm-Fixed-Price (FFP), Indefinite Delivery/Indefinite Quantity (IDIQ) Base contracts and resultant FFP/IDIQ Delivery Order contracts to be awarded on a per-Contract Line Item Number (CLIN) and per-Sub-Line Item Number (SLIN) basis for the procurement of FDA-cleared electro-therapeutic devices and accessories supporting non-opioid pain management for Veterans across all VA Medical Centers and Community-Based Outpatient Clinics. This solicitation recompetition of the expiring legacy TENS contract and expands the legacy TENS procurement program to include Interferential Current Therapy (IFC) devices, Short-Wave Diathermy (SWD) devices (thermal and non-thermal), and portable Neuromodulation systems - for the treatment of headache disorders to be inclusive all unique parent CLIN devices and the device accessories has enumerated at the discrete subordinate SLINs. The device accessories categorized as SLINs include but are not limited to electrodes, lead wires, power chargers, garment-based applicators, and associated other consumables. Each product of the ETMPM-TENS requirement is mapped to unique parent CLIN and a discrete subordinate SLINs with universal Minimum Technical Requirements (MTRs) applicable to all CLINs/SLINs and individual CLIN/SLIN-specific MTRs. Key Dates: RFP Questions Due-In Date: On or before but no later than October 5, 2026, at 3:00 PM CDT, questions received after this deadline may receive a Government response or receipt acknowledgement. Proposal Package and Product Samples Due-In Date: On or before but no later than October 19, 2026, at 3:00 PM CDT. Early proposal package and product samples are encouraged. Anticipated Award: The results of competition ultimately determine when and if award(s) can be made, but the VA intends to finalize award decisions on or before but no later than January 19, 2027, the expiration date of the legacy TENS contract. The VA reserves the right not to make an award or to make award on some CLINs/SLINs but not all the CLINs/SLINs enumerated in the solicitation. Proposal Package Submission Instructions: A responsive proposal is one that conforms to the solicitation in all material respects and complies fully with all instructions contained therein, including but not limited to Offerors’ certifications, representations, submission formatting, inclusion of all mandatory documentation, and the shipment of product samples to the VA’s Denver Logistic Services facility in Golden, Colorado in accordance with the product samples delivery requirements as stated throughout the RFP. Submission of a proposal package in response to Solicitation Number 36C79126R0011 is strictly voluntary. All costs associated with the preparation, development, and submission of proposals, proposal package documentation, and any required product samples shall be borne solely by the Offeror. The Department of Veterans Affairs will not reimburse, compensate, or otherwise pay Offerors for any expenses incurred in the preparation or submission of proposal materials or product samples. Offerors shall not invoice the Government for such costs. All proposal preparation and submission activities are performed at the Offeror’s own expense. Policy Note: In the event of a conflict between this Solicitation Notice posted at the Government-wide Point of Entry (GPE) website at https://www.sam.gov and solicitation number 36C79126R0011, the solicitation shall prevail, govern, and control. Proposal Packages must include but are not limited to the following: Properly Executed SF 1449: Complete the name/title, signature, and date signed Blocks 30a–30c of the SF 1449. Complete the information entries of all Section B Continuation Pages to include filling in all required YELLOW highlighted text fields for the Offeror’s primary point of contact. Include the fully executed SF 1449 as a separate document attachment to the proposal submission email message. Submission of a Technical Capability Statement: All Offerors shall submit a Technical Capability Statement that adequately demonstrates the Offeror’s capability to fulfill all universal MTRs and the CLINs/SLINs-specific MTRs for all offered products and adequately demonstrates the Offeror’s clear and complete understanding of the ETMPM-TENS requirement and the Offeror’s capability to deliver the required products as ordered within 30 calendar days of order receipt. The Technical Capability Statement shall be submitted as a separate document attachment to the proposal submission email message. OEM-issued Authorized Distributor Letters (Required for all Non-Manufacturers): Submit a current, valid OEM-issued Authorized Distributor Letter(s) accounting for all non-manufacturer products on a per-CLIN/SLIN basis. The OEM-issued Authorized Distributor Letters shall be submitted as a separate document attachment to the proposal submission email message. FDA Clearance Letters: All Offerors shall submit valid FDA 510(k) clearance letters/documentation or other applicable FDA authorization for every device and accessory offered on a per-CLIN/SLIN basis. The FDA Clearance Letters shall be submitted as a separate document attachment to the proposal submission email message. Past Performance Documentation: All Offerors shall submit the three (3) most recent official CPARS Evaluation Reports, if an Offeror is unable to submit completed CPARS Evaluation Reports due to a lack of past performance, the Offeror shall submit Past Performance Questionnaires (PPQs) completed by the Offeror’s three (3) most recent customers. All Offerors shall submit three (3) past performance documents for Government evaluation that may consist of a combination of official CPARS Evaluation Reports and/or Past Performance Questionnaires (PPQs). The PPQs shall be completed and submitted by the Offeror’s customer(s) directly to the VA’s Contract Specialist via separate document attachments to the PPQs submission email message. The Offeror submitted CPARS Evaluation Reports shall be submitted as a separate document attachment(s) to the proposal submission email message. Product Samples: All Offerors shall ship a product sample for every product offered on a per-CLINs/SLINs basis at no cost to the Government. Ship all required product samples for each proposed CLIN/SLIN to: Department of Veterans Affairs Denver Logistics Service (DLS) 555 Corporate Circle, Golden, CO 80401-5621 Attention: Javier Ramirez and Lisa Mello RFP Number 36C79126R0011 All product samples must be received by the Government personnel at the VA’s DLS facility on or before but no later than the common due-in date/time established for the receipt of all proposal submission in response to the issuance of Solicitation Number 36C79126R0011. The early submission of product samples is encouraged. All Required Solicitation Attachments: All Offerors are required to complete, certify, and submit all solicitation attachments (Attachment 0001 - Price Matrix, Attachment 0002- Offeror’s Representations and Certifications, Attachment 0003 - Limitations on Subcontracting, Attachment 0004 - Buy American Certificate, Attachment 0005 - Trade Agreements Certificate, and Attachment 0006 - Past Performance Questionnaire - utilized by Offerors on an as needed basis). The Attachments to this solicitation shall be submitted as a separate document attachment(s) to the proposal submission email message. Policy Note: If any conflict exists between offered end-product country-of-origin (COO) entries in Attachment 0002 (FAR 52.212-3) and Attachments 0004 (FAR 52.225-2) or 0005 (FAR 52.225-6), the entries in Attachments 0004 and 0005 shall govern for end-product COO eligibility and evaluation under FAR Part 25. The VA will rely on CLIN/SLIN-level COO declarations in these attachments for Buy American Act and Trade Agreements Act compliance. Proposal Package Documentation Submission Method: Submit all proposal documents electronically by email message with attached documents to: John Overstake, Primary Contract Specialist: john.overstake@va.gov; Carbon Copy (“CC”): Alternate Contract Specialist Susanna Huffmaster: susanna.huffmaster@va.gov>maurice.walker@va.gov; Carbon Copy (“CC”): Maurice Walker, Contracting Officer and Source Selection Authority: maurice.walker@va.gov; Use Email Subject Line: “Proposal Submission – RFP 36C79126R0011 – [Offeror Name]”; and The VA will confirm receipt of proposal packages by brief email reply message. Evaluation and Award Methodology: CLINs/SLINs X001–X004: Evaluated using Lowest Price Technically Acceptable (LPTA) source selection procedures. CLIN/SLIN X005 and X005AA: Evaluated using Best Value – Tradeoff source selection procedures. Responsiveness: Only proposals meeting all material requirements as stated in solicitation number 36C79126R0011 will be evaluated and considered for award. RFP Questions & Government Responses: All questions regarding this RFP must be submitted in writing by email message only addressed to John Overstake at email address john.overstake@va.gov, with a carbon copy (“CC”) message to Susanna Huffmaster: susanna.huffmaster@va.gov and a carbon copy (“CC”) message to maurice.walker@va.gov. All Offerors’ RFP questions shall be received on or before but no later than October 5, 2026, at 3:00 PM CDT. The VA will acknowledge receipt of all timely questions received. All Government responses to timely questions shall be posted on the GPE website at https://www.sam.gov on or before but no later than the common due-in date/time established for the receipt of all proposal submission in response to the issuance of Solicitation Number 36C79126R0011. Questions received after the established deadline for the receipt of all questions to the Government in response to the issuance of Solicitation Number 36C79126R0011 may not receive a Government receipt acknowledgement and may not receive a Government response at the sole discretion of the Government. Closing Statement: The Department of Veterans Affairs (VA) sincerely thanks all prospective Offerors for their interest and the significant effort required to prepare and submit responsive proposals. The VA recognizes the substantial commitment time, effort, and resources involved and commends your dedication to supporting our mission. Together, we serve those who have served our great nation with honor, courage, and commitment. It is our privilege to partner with industry participants in delivering the highest quality healthcare and support of America’s Veterans. For full details, instructions, and all solicitation documents, please download the complete RFP package and all six (6) solicitation attachments from this posting. (End of Solicitation Notice 36C79126R0011) Clarifications-Only No Changes Made: (Updated September 19,2026, Offerors' Questions and Government Responses document attached). Updated: September 21, 2026, added Prospective Offerors' Questions and Government's Clarifications document as an attachment to this notice. Updated: September 22, 2026, added Prospective Offerors' Questions and Government's Clarifications document as an attachment to this notice. Updated: September 28, 2026, added Prospective Offerors' Questions and Government's Clarifications document as an attachment document to this notice. Updated: September 28, 2026, a significant number of additional questions were received to justify adding an updated Prospective Offerors' Questions and Government's Clarifications document as an attachment document to this notice. Updated: September 29, 2026, a significant number of additional questions were received to justify adding an updated Prospective Offerors' Questions and Government's Clarifications document as an attachment document to this notice. (Updated September 30, 2026) AMENDMENT 00001 TO SOLICITATION NUMBER 36C79126R0011 ISSUED: Purpose: Amendment 00001 to Solicitation Number 36C79126R0011, Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) Requirement, is issued to implement mandatory corrections and clarifications identified during the Policy Quality Assurance (PQA) Division’s presolicitation review. This Amendment ensures the solicitation is fully compliant with current Federal Acquisition Regulation (FAR), VA Acquisition Regulation (VAAR), and VA policy requirements prior to continued proposal submission and evaluation. Summary of Key Revisions: Removal of Attachment 0003: Attachment 0003 (VAAR Clause 852.219-76, Limitations on Subcontracting) has been removed from the solicitation package as a material requirement. Offerors are no longer required to submit this attachment as part of their proposal. Removal of Attachment 0002 – FAR Provision 52.212-3: Attachment 0002 (FAR Provision 52.212-3, Offeror Representations and Certifications) is now “RESERVED” under the FAR overhaul and is no longer a material requirement. Offerors are not required to submit this document with their proposals. Correction of Clause References and Dates: All outdated or superseded FAR, RFO, and VAAR clause citations and dates have been updated throughout the solicitation to reflect current deviation dates and regulatory requirements. All “RESERVED” clauses (e.g., 52.212-3, 52.212-5, 852.246-70) and invalid references (e.g., VAAR 852.270-1) have been removed. Addition and Correction of VAAR Clauses: VAAR 852.219-10 has been replaced with VAAR 852.219-73 (VA Notice of Total SDVOSB Set-Aside). VAAR 852.212-71 (Gray Market and Counterfeit Items) has been added. VAAR 852.211-70 and 852.211-72 are now incorporated by full text with required CLIN-specific fill-ins. Correction of Source Selection and Evaluation Citations: All references to source selection procedures have been corrected to cite the appropriate RFO provisions (e.g., LPTA procedures now cite RFO 15.103-2). The Certificate of Competency referral citation is corrected to RFO 19.204. Correction of Attachment Numbering and Instructions: All attachment references have been corrected for accuracy. Instructions for completing Attachment 0001 – Price Matrix now include all CLINs/SLINs (including X003 and X004), and decimal quantity errors have been corrected to display whole numbers. Update of Hyperlinks: All hyperlinks to FAR/RFO full-text repositories have been updated to the correct deviation guide URL. Clarification of Evaluation Factor Importance: The relative importance statement for CLINs X001-X004 has been clarified to state that price is the deciding factor under LPTA procedures. What Remains Unchanged: Scope and Objectives: The overall scope, objectives, and technical requirements of the ETMPM-TENS procurement remain unchanged. The solicitation continues to seek proposals for FDA-cleared electrotherapeutic devices and accessories as described in the Statement of Need and Minimum Technical Requirements. Tiered Set Aside Evaluation Methodology and Competition Approach: The source selection methodology (LPTA for CLINs X001-X004, Best Value Tradeoff for CLIN X005), tiered set-aside evaluation approach, and all other competition procedures remain unchanged. Proposal Submission Instructions: The process for submitting proposals, including the requirement to submit a signed SF 1449, completed Section B entries, Technical Capability Statement, and all required attachments (except those removed by this amendment), remains unchanged. Instructions to Offerors: Offerors are advised to carefully review the revised solicitation and all attachments. All proposals must conform to the updated requirements and instructions. Proposals that do not comply with the revised solicitation, including the removal of Attachment 0002 and Attachment 0003 as material requirements, may be deemed nonresponsive. Conclusion: Amendment 00001 is issued to ensure full compliance with current regulatory requirements and to clarify proposal submission obligations. No substantive changes have been made to the acquisition strategy, evaluation methodology, or competition approach. All other terms and conditions of Solicitation Number 36C79126R0011 remain unchanged. (End of Amendment 0001 Explanation) (Updated October 02, 2026) Solicitation Number 36C79126R0011 Amendment 0002 Issued: Purpose of Amendment: Amendment 0002 to Solicitation 36C79126R0011 was issued to address critical clarifications and corrections necessary for the Electro-Therapeutic Modalities for Pain Management (ETMPM) procurement program. This amendment ensures that all technical requirements, pricing instructions, and regulatory clauses are fully aligned with the Government’s intent and industry standards, thereby supporting a fair, transparent, and competitive acquisition process. Background and Rationale: During the initial solicitation phase, several discrepancies and ambiguities were identified in the unit of issue definitions, SLIN-level Minimum Technical Requirements (MTRs), and pricing instructions. Additionally, feedback from prospective Offerors and internal Government review highlighted the need to revise certain clauses and correct errors in the solicitation attachments. These issues, if left unaddressed, could have resulted in confusion, inconsistent proposal submissions, and potential protest risk. Summary of Revisions and Changes: Revision of SLIN-Level MTRs for Unit of Issue (Each - EA): Amendment 0002 clarifies and standardizes the unit of issue for all SLINs as “Each (EA)” throughout the solicitation. This ensures that Offerors price and deliver products consistently, with each SLIN representing a package of four (4) electrodes as the unit of issue. All product samples must be shipped to the VA’s Denver Logistics Service (DLS) Facility in the unit of issue EA, which equals one (1) device for CLINs and one (1) package of four electrodes for SLINs. Revision of Attachment 0003 – VAAR Clause 852.219-76 Limitations on Subcontracting: The clause was updated for alignment under the Request for Offer (RFO) and Federal Acquisition Regulation (FAR), ensuring compliance with VA-specific subcontracting limitations and promoting opportunities for small business participation. Correction of SLINs X001AC and X002AC Material Requirements: Amendment 0002 removes the requirement for 2 in. x 4 in. electrodes from SLIN X001AC and X002AC, aligning the material requirements with clinical needs and industry standards. All SLINs are now priced as a package of four electrodes, eliminating ambiguity and ensuring uniformity across all proposals. Revision of Attachment 0001 – Price Matrix: The Price Matrix was corrected to address Government errors in the Excel spreadsheet, ensuring accurate entry of unit pricing for all CLIN/SLIN groupings. This revision supports clear, auditable pricing submissions and facilitates effective evaluation of proposals. Clarification of Proposal Submission and Sample Shipping Requirements: Amendment 0002 reiterates that all pricing and sample shipments must adhere to the revised unit of issue EA, with explicit instructions for packaging and labeling. This change mitigates risk of misinterpretation and supports efficient receipt and evaluation of product samples at the VA’s DLS Facility. Conclusion: Amendment 0002 was necessary to resolve inconsistencies, clarify technical and pricing requirements, and ensure regulatory compliance within Solicitation 36C79126R0011. These revisions promote fairness, transparency, and operational efficiency in the ETMPM-TENS procurement process, supporting the VA’s mission to deliver safe, effective, non-opioid pain management solutions for Veterans. (End of Amendment 0002 Explanation) (Updated 10/06/2026 - Amendment 0003 to Solicitation Number 36C79126R0011 Issued - Solicitation Number 36C79126R0011 as Revised by Amendment 0003 is in full force and effect.) Amendment 0003 to Solicitation Number 36C79126R0011 includes the following seven revisions: Removal of Attachment 0004 – BAA Certificate and all related solicitation language. New Mandatory Requirement for Separate Attachment 0001 – Price Matrix Files for Each Alternate Electrode Option (AD SLINs). Clarification of How the VA “Rule of Two” Applies Under Tiered Evaluation. Clarification That AD SLINs Must Always Be Included in the Primary TEP Matrix (Not Optional). Clarification That Multiple AD Matrices Supplement—but Do Not Replace—the Required Primary Price Matrix. Minor Clarifying Adjustments to Related Sections (Non‑Substantive), including sample labeling and compatibility evaluation. Retention of Attachment 0003 – VAAR 852.219‑76 Limitations on Subcontracting Certificate.Amendment 0003 to Solicitation 36C79126R0011 is issued to strengthen clarity, consistency, and evaluation integrity within the ETMPM‑TENS national procurement program. Since the solicitation’s release on September 18, 2026, and following more than one-hundred (100 +) prospective Offerors’ questions submitted by the October 5, 2026, Q&A submission deadline, the VA identified several areas requiring formal clarification to preserve fair competition and defensible source selection. The need for this amendment arises from the evolving understanding of how Offerors intend to structure alternate electrode (AD) offer submissions, how end-product country-of-origin (COO) certifications apply under a TAA‑only procurement, and how mandatory small-business compliance documents are to be properly enforced. Earlier amendments corrected pricing tables, SLIN units of issue, and MTRs alignment, but did not address structural submission and evaluation alignment issues revealed during prospective Offerors engagement. Amendment 0003 therefore incorporates seven (7) targeted revisions. (Updated October 09, 2026) Final Q&A document uploaded as an attachment to the Solicitation Notice Number 36C79126R0011 as revised by Amendment 0003. (Updated October 15, 2026, Amendment 0004 to Solicitation Number 36C79126R0011 issued this date.) Ammendment 0004 incorporates a change in the common response date for the receipt of all proposals and the receipt of all product samples from October 19, 2026, at 3:00PM CDT, to October 30, 2026, at 3:00PM CDT. (Updated October 16, 2026, Amendment 0005 to Soliciation Number 36C79126R0011 issued this date.) Amendment 0005 incorporates the revision of the material reqirements of the Tier-based end-product country-of-origin certification as follows: Attachment 0004 - FAR Provision 52.225-2 Buy American Certificate is added back to Solicitation Number 36C79126R0011, this attachment was removed by Amendment 0003 to Solicitation Number 36C79126R0011, but now added back as an Attachment by Amendment 0005. Awards at Tiers 1 - 3 are in effect and shall be treated by the VA as Total Small Business Set Asides and therefore all Offerors who are designated as small business concerns under NAICS Code 334510 shall as a material requirement of responsiveness submit a Attachment 0004 - FAR Provision 52.225-2 Buy American Certificate. Award ar Tier 4 are in effect and shall be treated by the VA as an award made under unrestricted competition and therefore all Offerors who are designated as Other-Than-Small Business concerns under NAICS Code 334510 shall as a mterial requirement of responsiness submit a Attachment 0005 - FAR Provision 52.225-6 Trade Agreement Certificate. All Offerors who have already submitted a proposal package and are now required by Amendment 0005 to Solicitation Number 36C79126R0011 to submit a responsive Attachment 0004 - FAR Provision 52.225-2 Buy American Certificate shall submit/resubmit the Attachment 0004 - FAR Provision 52.225-2 Buy American Certificate electronically as an attachment to an email message addressed to the VA's POCs listed with the Solicitation as soon as possible but no later than common response date for the receipt of all proposals and receipt of all product samples for all products offered against Solitation Number 36C79126R001 which remains unchanged as October 30, 2026, at 3:00PM CDT. (Updated October 26, 2026, Amendment 0006 to Soliciation Number 36C79126R0011 issued this date.) Amendment 0006 Issued | Solicitation Number 36C79126R0011 | Revised Solicitation Package and Attachments 0001–0006 The Department of Veterans Affairs (VA), Enterprise Procurement Office, hereby announces the issuance of Amendment 0006 to Solicitation Number 36C79126R0011 for the FY26 Recompete of the Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program. Amendment 0006 and the revised solicitation package are attached to this notice. Documents Included: Revised Solicitation Number 36C79126R0011, as amended through Amendment 0006 Attachment 0001 – Price Matrix Attachment 0003 – Certificate of Compliance / Limitations on Subcontracting Attachment 0004 – Buy American Certificate Attachment 0005 – Trade Agreements Certificate Attachment 0006 – Offeror Past Performance Questionnaire (PPQ) Amendment 0006 SF-30 and associated amendment documentation Summary: Amendment 0006 incorporates revisions intended to improve solicitation clarity, eliminate inconsistencies, and provide additional guidance regarding: Proposal submission requirements Evaluation procedures Country-of-origin requirements Applicable certifications and supporting documentation Administrative and technical solicitation clarifications Prospective Offerors are encouraged to review Amendment 0006 and all associated attachments in their entirety. Proposal Submission Deadline: The Contracting Officer has extended the common date and time for the receipt of all proposal package documentation and the receipt of required product samples. The previous deadline of October 30, 2026, at 3:00 PM CDT is hereby revised. All proposal documentation and all required product samples must now be received no later than November 2, 2026, at 12:00 PM CDT, in accordance with Amendment 0006. Important Notice: The solicitation, as amended, together with all formally issued amendments, constitutes the complete and controlling solicitation package. Prospective Offerors should ensure that proposal submissions fully account for all applicable revisions contained in Amendments 0001 through 0006. If an Offeror identifies an apparent ambiguity, inconsistency, omission, or conflict within the solicitation documents, the Offeror remains responsible for raising the matter in accordance with the solicitation instructions and applicable procurement procedures. The VA appreciates the interest and participation of all prospective Offerors in support of this procurement and the Department's mission to provide effective non-opioid pain-management solutions for Veterans. (Updated October 30, 2026, Amendment 0007 to Soliciation Number 36C79126R0011 issued this date.) Summary of Changes – Amendment 0007 The purpose of this amendment is to provide the following clarifications to the solicitation: 1. RFO Clause 52.225-1, Buy American - Supplies (BAA), applies to Tiers 1–3 as does the Provision at RFO 52.225-2, Buy American Certificate. RFO Clause 52.225-5, Trade Agreements (TAA), applies to Tier 4 as does the Provision at RFO 52.225-6, Trade Agreements Certificate. 2. The Government will apply the applicable Buy American price evaluation factors under FAR 25.106 when determining the total evaluated price (TEP) for Tiers 1–3 price factor evaluations. 3. If evaluation proceeds to Tier 4, the Government will conduct discussions to allow small business Offerors to submit the applicable Attachment 0005 - Trade Agreements Certificate and a revised OEM Authorized Distributor Letter reflecting compliance with the Trade Agreements Act. 4. Block 10 has been changed from Unrestricted to unchecked but per the terms of the solicitation this is being issue pursuant to the tiered evaluation established therein. 5. For CLINs X001–X004, revise the MTR language from “Device must include a visual display with back lighting, visual display shall have adequate readability in typical clinical/home lighting conditions (e.g., backlighting or equivalent illumination and readability)” to “Device must include a visual display with back lighting or equivalent illumination”. All other terms and conditions of Solicitation 36C79126R0011 as revised by Amendment 0007, remain unchanged and in full force and effect. The VA looks forward to receiving your responsive proposal packages and required product samples no later than 12:00 PM CDT on November 2, 2026. (Updated v2 October 30, 2026, Amendment 0007 to Soliciation Number 36C79126R0011 issued this date.) The Solicitation Amendment 0007 Document contained a clerical error that needed to be corrected. A new revised document has been uploaded. Nothing else has changed other than the clerical error.
100%
Solicitation11/02/2026
VA has identified Cochlear Implants (CI) and Auditory Osseointegrated Implants (AOI) and related products/supplies/accessories as a continued requirement in support of both VA and the Department of Defense (DoD) approved medical facilities. Cochlear Implants and Auditory Osseointegrated Implants are currently provided through multiple firmfixed price, indefinite delivery/indefinite quantity (IDIQ) contracts. These current contracts are managed by the Denver Logistics Service (DLS) and administered by the Commodities and Services Acquisition Service (CSAS) in support of the Prosthetic and Sensory Aids Services (PSAS). The purpose is to define the requirements for Auditory Implant systems (CIs and AOIs), replacement parts and accessories compatible with CIs and AOIs to both the VA and DoD. The VA has identified OEM customized (prescription) implants, processors, wireless devices, and accessories. as preferred products for this contract. The objectives are to: 1. Establish multiple sole-source awarded contracts that can serve the entire United States and its territories for customized (prescription) auditory implants and repairs to eligible Veterans and beneficiaries using standardized ordering processes. 2. Obtain quality products at a significant discount compared to the commercial market prices. 3. Ensure availability and consistency of products for nationwide usage while integrating the DLS Remote Order Entry System (ROES) program for ordering. VA Audiologists shall order auditory implant contracted line items through the national ROES. 4. Improve operating efficiency throughout the VA. 5. This contract will also allow for higher level of effective communication between the Government and the Contractor, which is essential for partnering for this performance-based contract to succeed. The success of this contract is mutually erected through good communication between the Government and the Contractor. Indefinite Delivery Indefinite Quantity (IDIQ) contract(s) will be for a oneyear base period and nine (9) one-year option periods. and will be used as a primary source by the VA. Other approved Government agencies are the Department of Defense (DoD) and Indian Health Services (IHS) will be authorized and able to procure contract line items by placing orders directly utilizing contractors’ commercial system. Option periods will or will not be exercised at the sole discretion of the Government. This contract was awarded as a FFP IDIQ Sole Source award.
74%
AwardedOpen
VA has identified Cochlear Implants (CI) and Auditory Osseointegrated Implants (AOI) and related products/supplies/accessories as a continued requirement in support of both VA and the Department of Defense (DoD) approved medical facilities. Cochlear Implants and Auditory Osseointegrated Implants are currently provided through multiple firmfixed price, indefinite delivery/indefinite quantity (IDIQ) contracts. These current contracts are managed by the Denver Logistics Service (DLS) and administered by the Commodities and Services Acquisition Service (CSAS) in support of the Prosthetic and Sensory Aids Services (PSAS). The purpose is to define the requirements for Auditory Implant systems (CIs and AOIs), replacement parts and accessories compatible with CIs and AOIs to both the VA and DoD. The VA has identified OEM customized (prescription) implants, processors, wireless devices, and accessories. as preferred products for this contract. The objectives are to: 1. Establish multiple sole-source awarded contracts that can serve the entire United States and its territories for customized (prescription) auditory implants and repairs to eligible Veterans and beneficiaries using standardized ordering processes. 2. Obtain quality products at a significant discount compared to the commercial market prices. 3. Ensure availability and consistency of products for nationwide usage while integrating the DLS Remote Order Entry System (ROES) program for ordering. VA Audiologists shall order auditory implant contracted line items through the national ROES. 4. Improve operating efficiency throughout the VA. 5. This contract will also allow for higher level of effective communication between the Government and the Contractor, which is essential for partnering for this performance-based contract to succeed. The success of this contract is mutually erected through good communication between the Government and the Contractor. Indefinite Delivery Indefinite Quantity (IDIQ) contract(s) will be for a oneyear base period and nine (9) one-year option periods. and will be used as a primary source by the VA. Other approved Government agencies are the Department of Defense (DoD) and Indian Health Services (IHS) will be authorized and able to procure contract line items by placing orders directly utilizing contractors’ commercial system. Option periods will or will not be exercised at the sole discretion of the Government. This contract was awarded as a FFP IDIQ Sole Source award.
74%
AwardedOpen
VA has identified Cochlear Implants (CI) and Auditory Osseointegrated Implants (AOI) and related products/supplies/accessories as a continued requirement in support of both VA and the Department of Defense (DoD) approved medical facilities. Cochlear Implants and Auditory Osseointegrated Implants are currently provided through multiple firmfixed price, indefinite delivery/indefinite quantity (IDIQ) contracts. These current contracts are managed by the Denver Logistics Service (DLS) and administered by the Commodities and Services Acquisition Service (CSAS) in support of the Prosthetic and Sensory Aids Services (PSAS). The purpose is to define the requirements for Auditory Implant systems (CIs and AOIs), replacement parts and accessories compatible with CIs and AOIs to both the VA and DoD. The VA has identified OEM customized (prescription) implants, processors, wireless devices, and accessories. as preferred products for this contract. The objectives are to: 1. Establish multiple sole-source awarded contracts that can serve the entire United States and its territories for customized (prescription) auditory implants and repairs to eligible Veterans and beneficiaries using standardized ordering processes. 2. Obtain quality products at a significant discount compared to the commercial market prices. 3. Ensure availability and consistency of products for nationwide usage while integrating the DLS Remote Order Entry System (ROES) program for ordering. VA Audiologists shall order auditory implant contracted line items through the national ROES. 4. Improve operating efficiency throughout the VA. 5. This contract will also allow for higher level of effective communication between the Government and the Contractor, which is essential for partnering for this performance-based contract to succeed. The success of this contract is mutually erected through good communication between the Government and the Contractor. ndefinite Delivery Indefinite Quantity (IDIQ) contract(s) will be for a oneyear base period and nine (9) one-year option periods. and will be used as a primary source by the VA. Other approved Government agencies are the Department of Defense (DoD) and Indian Health Services (IHS) will be authorized and able to procure contract line items by placing orders directly utilizing contractors’ commercial system. Option periods will or will not be exercised at the sole discretion of the Government. This contract was awarded as a FFP IDIQ Sole Source award.
74%
AwardedOpen
69%
AwardedOpen

Additional Details

Solicitation Number

36C791-27-AP-0004-0002

Archive Date

Sep 26, 2026

Office Address

DENVER, CO, 80225